Abstract
Thalidomide exerts synergistic or additive effects when combined with other drugs. This study reports the toxicity and efficacy of the combination of thalidomide plus oral melphalan in 27 patients with advanced multiple myeloma. We found that this combination induces a high response rate and a long progression-free survival without significantly increasing thalidomide-related toxicity.
Original language | English |
---|---|
Pages (from-to) | 1432-1433 |
Number of pages | 2 |
Journal | Haematologica |
Volume | 88 |
Issue number | 12 |
Publication status | Published - Dec 2003 |
Keywords
- Melphalan
- Multiple myeloma
- Thalidomide
ASJC Scopus subject areas
- Hematology